Olympus launches next-generation VISERA ELITE III surgical imaging platform in US

Olympus Corporation has launched the VISERA ELITE III surgical imaging platform designed to enhance surgical visualization, workflow efficiency and multispecialty flexibility, in the US. The VISERA ELITE III platform is a significant leap forward in surgical imaging and the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture established in 2013.

The VISERA ELITE III surgical imaging platform offers advanced features including Yellow Enhancement (YE) and Fluorescence-Guided Surgery (IR/ICG) in full 4K White Light and high contrast Magenta Mode as shown above

Designed to bring light, colour and clarity inside the human body, the VISERA ELITE III platform integrates advanced imaging technologies into a software-driven platform that supports minimally invasive surgery in a wide range of specialties. The advanced features in this next-generation surgical imaging platform include True 4K and 3D imaging, Continuous Auto Focus (CAF), Narrow Band Imaging (NBI) technology, Yellow Enhancement (YE), ENDOEYE rigid and flexible videoscopes, and Fluorescence-Guided Surgery (IR/ICG) - now in full 4K White Light and high contrast Magenta Mode. All these features are now available in a single system that may improve workflow and may support clinical decision making.

The versatile, multispecialty VISERA ELITE III platform supports a wide range of specialties including arthroscopy, colorectal, ENT, bariatric, thoracic, gynaecological, urological, HPB transplant and general surgery. This flexibility across specialties and support for prior generation videoendoscopes reflects Olympus' commitment to scalable, clinical solutions that evolve with surgical teams' needs.

"VISERA ELITE III is more than a platform - it's a strategic enabler for modern operating rooms and is a cornerstone of Olympus' SEE. TREAT. CONNECT. ecosystem," said Darryl Rock, Vice President and Surgical Solutions Regional Business Lead at Olympus Corporation of the Americas. "Its software-based architecture allows hospitals to scale capabilities while controlling capital investment and selectively activate advanced features like 3D and infrared imaging as needed. By seamlessly integrating data into electronic health records and IT systems, VISERA ELITE III may facilitate flexibility and clinical workflow and enable clinicians to focus on what matters most - delivering high-quality care while optimizing their investment."

Key clinical benefits include:

• Comprehensive Advanced Imaging: True 4K, 3D, Narrow Band Imaging (NBI) technology, Yellow Enhancement (YE), and Fluorescence-Guided Surgery (IR/ICG) in one system.

• Critical Structure Identification: 8 out of 10 surgeons surveyed in 2025 agreed that YE may assist in identifying vessels, nerves, and critical structures within adipose tissue.

• Improved Outcomes: 3D imaging with horizon lock reduces surgical suturing time when compared to 2D imaging and may enhance laparoscopic precision. IR/ICG imaging provides visualization for perfusion assessment and resection margin accuracy, potentially reducing anastomotic leak rates.

• Enhanced Visualisation: Multiple IR modes, proprietary high-efficiency LED, and adjustable IR gain optimize fluorescence visibility.

• Clarity: Sharp images through True 4K CMOS sensor and Continuous Auto Focus (CAF) function helps users to never lose focus.vi

• Integrated IT: Stream clinical and room video, automate workflows, and enable seamless EHR integration with video capture and documentation through the Olympus VaultStream and LiveStream portals.

"With use of indocyanine green during surgery, I can see the perfusion of the connection clearly, and I can continue dissecting with confidence," said Dr Natan Zundel, bariatric and metabolic surgeon with Jackson Health in Miami, Florida.

Investing in the VISERA ELITE III platform delivers measurable economic benefits by enabling operating room standardisation. Its ability to support multiple specialties reduces equipment redundancy and streamlines workflows. Additionally, the VISERA ELITE III platform supports Olympus' comprehensive multispecialty scope portfolio, including rigid and flexible videoscopes, 3D and ENDOEYE video laparoscopes. The platform is compatible with previous Olympus camera and scope generations, maximising the lifespan of existing equipment.

The VISERA ELITE III Imaging Platform is a compact, multispecialty imaging platform designed for laparoscopic diagnosis, treatment, and video observation. TYPE BF endoscopes connected to this imaging platform must never be applied directly to the heart. Leakage current from the TYPE BF applied part may be dangerous and cause ventricular fibrillation or otherwise seriously affect the cardiac function of the patient.

The VISERA ELITE III platform is now available in all global regions, including the US.